insights_auto
Kwa nini ONCY imeongezeka kwa 2.31%?
Fahamu zaidichevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
US$Â 0.56
arrow_upward
+2.31%(+0.013) Siku 1
US$Â 0.55
arrow_downward
-1.26% (-0.0070)bedtimeBaada ya saa
Imefungwa: 9 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ONCY...
Fungua
US$Â 0.55
Juu
US$Â 0.57
Chini
US$Â 0.52
Mtaji wa soko
73.03M
Wastani wa kiasi cha mauzo
1.05M
Kiasi cha mauzo ya hisa
1.46M
Juu kwa wiki 52
US$Â 1.32
Chini kwa wiki 52
US$Â 0.52
Beta
1.15
Hisa za wawekezaji
127.51M
Idadi ya wafanyakazi
29
Fungua
US$Â 0.55
Juu
US$Â 0.57
Chini
US$Â 0.52
Mtaji wa soko
73.03M
Wastani wa kiasi cha mauzo
1.05M
Kiasi cha mauzo ya hisa
1.46M
Juu kwa wiki 52
US$Â 1.32
Chini kwa wiki 52
US$Â 0.52
Beta
1.15
Hisa za wawekezaji
127.51M
Idadi ya wafanyakazi
29
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
https://www.dars.gov.et/
·
mwezi 1 uliopita
Oncolytics Biotech (ONCY) Holds Near $0.82 as Shares Edge Up 0.49% - Time Weighted Price
Wasifu
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Kuhusu Oncolytics Biotech Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi29
Lilianzishwa1998
Makao makuuCalgary, Alberta, Kanada
Sekta-
Tovutioncolyticsbiotech.com